NUVEEN MN QLTY MUNI INC (NMS) Fundamental Analysis & Valuation

NYSE:NMS • US6707341029

12.01 USD
-0.04 (-0.29%)
Last: Mar 11, 2026, 08:15 PM
Overview Stock Chart Technical Analysis News

This NMS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

2

Overall NMS gets a fundamental rating of 2 out of 10. We evaluated NMS against 0 industry peers in the Unkown industry. NMS has a bad profitability rating. Also its financial health evaluation is rather negative. NMS has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

2

1. NMS Profitability Analysis

1.1 Basic Checks

  • NMS had positive earnings in the past year.
  • NMS had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: NMS reported negative net income in multiple years.
  • Each year in the past 5 years NMS had a positive operating cash flow.
NMS Yearly Net Income VS EBIT VS OCF VS FCFNMS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M -5M

1.2 Ratios

  • The 3 year average ROIC (0.75%) for NMS is below the current ROIC(1.22%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -0.22%
ROE -0.37%
ROIC 1.22%
ROA(3y)-0.4%
ROA(5y)-0.24%
ROE(3y)-0.67%
ROE(5y)-0.54%
ROIC(3y)0.75%
ROIC(5y)1.17%
NMS Yearly ROA, ROE, ROICNMS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 -5

1.3 Margins

  • NMS's Operating Margin has declined in the last couple of years.
  • In the last couple of years the Gross Margin of NMS has declined.
Industry RankSector Rank
OM 37.78%
PM (TTM) N/A
GM 39.63%
OM growth 3Y-15.03%
OM growth 5Y-8.33%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.36%
GM growth 5Y-7.87%
NMS Yearly Profit, Operating, Gross MarginsNMS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100 -100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. NMS Health Analysis

2.1 Basic Checks

  • NMS has more shares outstanding than it did 1 year ago.
  • NMS has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, NMS has a worse debt to assets ratio.
NMS Yearly Shares OutstandingNMS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M
NMS Yearly Total Debt VS Total AssetsNMS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M

2.2 Solvency

  • NMS has an Altman-Z score of 0.86. This is a bad value and indicates that NMS is not financially healthy and even has some risk of bankruptcy.
  • The Debt to FCF ratio of NMS is 27.47, which is on the high side as it means it would take NMS, 27.47 years of fcf income to pay off all of its debts.
  • A Debt/Equity ratio of 0.72 indicates that NMS is somewhat dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.72
Debt/FCF 27.47
Altman-Z 0.86
ROIC/WACCN/A
WACCN/A
NMS Yearly LT Debt VS Equity VS FCFNMS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M 40M 60M 80M

2.3 Liquidity

  • A Current Ratio of 3.05 indicates that NMS has no problem at all paying its short term obligations.
  • NMS has a Quick Ratio of 3.05. This indicates that NMS is financially healthy and has no problem in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 3.05
Quick Ratio 3.05
NMS Yearly Current Assets VS Current LiabilitesNMS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1M 2M 3M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. NMS Growth Analysis

3.1 Past

  • NMS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -93.75%.
  • Looking at the last year, NMS shows a very strong growth in Revenue. The Revenue has grown by 22.98%.
  • NMS shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -1.34% yearly.
EPS 1Y (TTM)-93.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-416.67%
Revenue 1Y (TTM)22.98%
Revenue growth 3Y6.69%
Revenue growth 5Y-1.34%
Sales Q2Q%-17.84%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NMS Yearly Revenue VS EstimatesNMS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M

More info and screens

Find the best growth stocksShow best growing peers

0

4. NMS Valuation Analysis

4.1 Price/Earnings Ratio

  • NMS is valuated quite expensively with a Price/Earnings ratio of 600.50.
  • NMS's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 26.15.
Industry RankSector Rank
PE 600.5
Fwd PE N/A
NMS Price Earnings VS Forward Price EarningsNMS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 40.58
EV/EBITDA N/A
NMS Per share dataNMS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. NMS Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 6.95%, NMS is a good candidate for dividend investing.
  • NMS's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 6.95%

5.2 History

  • The dividend of NMS is nicely growing with an annual growth rate of 7.22%!
  • NMS has been paying a dividend for at least 10 years, so it has a reliable track record.
  • NMS has decreased its dividend recently.
Dividend Growth(5Y)7.22%
Div Incr Years1
Div Non Decr Years1
NMS Yearly Dividends per shareNMS Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6 0.8

5.3 Sustainability

  • NMS has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-1865.38%
EPS Next 2YN/A
EPS Next 3YN/A
NMS Yearly Income VS Free CF VS DividendNMS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M -5M

More info and screens

Find the best dividend stocksShow peers with best dividend

NMS Fundamentals: All Metrics, Ratios and Statistics

NUVEEN MN QLTY MUNI INC

NYSE:NMS (3/11/2026, 8:15:40 PM)

12.01

-0.04 (-0.29%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners9.87%
Inst Owner Change13.63%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap73.86M
Revenue(TTM)4.87M
Net Income(TTM)-260.00K
Analysts0
Price TargetN/A
Short Float %0.08%
Short Ratio0.25
Dividend
Industry RankSector Rank
Dividend Yield 6.95%
Yearly Dividend0.82
Dividend Growth(5Y)7.22%
DP-1865.38%
Div Incr Years1
Div Non Decr Years1
Ex-Date02-13
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 600.5
Fwd PE N/A
P/S 15.17
P/FCF 40.58
P/OCF 40.58
P/B 1.06
P/tB 1.06
EV/EBITDA N/A
EPS(TTM)0.02
EY0.17%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.3
FCFY2.46%
OCF(TTM)0.3
OCFY2.46%
SpS0.79
BVpS11.38
TBVpS11.38
PEG (NY)N/A
PEG (5Y)N/A
Graham Number2.26
Profitability
Industry RankSector Rank
ROA -0.22%
ROE -0.37%
ROCE 1.54%
ROIC 1.22%
ROICexc 1.22%
ROICexgc 1.22%
OM 37.78%
PM (TTM) N/A
GM 39.63%
FCFM 37.37%
ROA(3y)-0.4%
ROA(5y)-0.24%
ROE(3y)-0.67%
ROE(5y)-0.54%
ROIC(3y)0.75%
ROIC(5y)1.17%
ROICexc(3y)0.75%
ROICexc(5y)1.18%
ROICexgc(3y)0.75%
ROICexgc(5y)1.18%
ROCE(3y)0.96%
ROCE(5y)1.48%
ROICexgc growth 3Y-6.82%
ROICexgc growth 5Y-6.93%
ROICexc growth 3Y-6.82%
ROICexc growth 5Y-6.93%
OM growth 3Y-15.03%
OM growth 5Y-8.33%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.36%
GM growth 5Y-7.87%
F-Score4
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.72
Debt/FCF 27.47
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 0.87
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.05
Quick Ratio 3.05
Altman-Z 0.86
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-93.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-416.67%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)22.98%
Revenue growth 3Y6.69%
Revenue growth 5Y-1.34%
Sales Q2Q%-17.84%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y116.47%
EBIT growth 3Y-9.35%
EBIT growth 5Y-9.55%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-34.53%
FCF growth 3Y-30.71%
FCF growth 5Y-13.65%
OCF growth 1Y-34.53%
OCF growth 3Y-30.71%
OCF growth 5Y-13.65%

NUVEEN MN QLTY MUNI INC / NMS FAQ

Can you provide the ChartMill fundamental rating for NUVEEN MN QLTY MUNI INC?

ChartMill assigns a fundamental rating of 2 / 10 to NMS.


What is the valuation status for NMS stock?

ChartMill assigns a valuation rating of 0 / 10 to NUVEEN MN QLTY MUNI INC (NMS). This can be considered as Overvalued.


How profitable is NUVEEN MN QLTY MUNI INC (NMS) stock?

NUVEEN MN QLTY MUNI INC (NMS) has a profitability rating of 2 / 10.


Can you provide the financial health for NMS stock?

The financial health rating of NUVEEN MN QLTY MUNI INC (NMS) is 2 / 10.